|
AEBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.822600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.832200E-02 |
| Normal-vs-Stage2 |
2.090800E-01 |
| Normal-vs-Stage3 |
4.991700E-04 |
| Normal-vs-Stage4 |
4.18770000000235E-05 |
| Stage1-vs-Stage2 |
9.340800E-01 |
| Stage1-vs-Stage3 |
3.407800E-02 |
| Stage1-vs-Stage4 |
7.622300E-03 |
| Stage2-vs-Stage3 |
2.458000E-01 |
| Stage2-vs-Stage4 |
1.787650E-01 |
| Stage3-vs-Stage4 |
7.377600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.971100E-04 |
| Normal-vs-AfricanAmerican |
4.415200E-03 |
| Normal-vs-Asian |
7.256000E-01 |
| Caucasian-vs-AfricanAmerican |
5.961200E-01 |
| Caucasian-vs-Asian |
2.504800E-01 |
| AfricanAmerican-vs-Asian |
1.188200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.625400E-04 |
| Normal-vs-Female |
3.226000E-02 |
| Male-vs-Female |
1.389990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.154590E-01 |
| Normal-vs-Age(41-60Yrs) |
1.520040E-02 |
| Normal-vs-Age(61-80Yrs) |
4.003500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.041800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.462000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.335800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.571400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.393200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.480400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.702200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.913200E-01 |
| Normal-vs-Grade 2 |
2.900600E-01 |
| Normal-vs-Grade 3 |
4.93060000050782E-07 |
| Normal-vs-Grade 4 |
1.36780000004055E-06 |
| Grade 1-vs-Grade 2 |
4.727000E-01 |
| Grade 1-vs-Grade 3 |
3.892200E-02 |
| Grade 1-vs-Grade 4 |
3.338100E-03 |
| Grade 2-vs-Grade 3 |
3.565800E-04 |
| Grade 2-vs-Grade 4 |
1.001230E-04 |
| Grade 3-vs-Grade 4 |
1.332610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.434600E-01 |
| Normal-vs-ccB subtype |
1.176730E-03 |
| ccA subtype-vs-ccB subtype |
7.782800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.328260E-02 |
| Normal-vs-N1 |
7.783900E-03 |
| N0-vs-N1 |
3.474800E-01 |
|
|
